IDiyas

For the Inventor, By the Inventor

Stockholm, NJ, United States of America

Brian Herbert

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 223(Granted Patents)


Company Filing History:

goldMedal20 out of 40 
 
Memory Pharmaceuticals Corporation
 patents
silverMedal1 out of 2 
 
Memory Pharmaceutical Corporation
 patents

Years Active: 2007-2014

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents
1. 8691841 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2014-04-08),
2. 8486937 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof (2013-07-16),
3. 8273891 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof (2012-09-25),
4. 8263619 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof (2012-09-11),
5. 8252811 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2012-08-28),
6. 8158629 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2012-04-17),
7. 8134003 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2012-03-13),
8. 8106066 - Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof (2012-01-31),
9. 7994199 - Heterocyclic compounds, methods for the preparation thereof, and uses thereof (2011-08-09),
10. 7964600 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2011-06-21),
11. 7943773 - Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof (2011-05-17),
12. 7932248 - 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof (2011-04-26),
13. 7902217 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof (2011-03-08),
14. 7790722 - Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof (2010-09-07),
15. 7700630 - Heterocyclic compounds, methods for the preparation thereof, and uses thereof (2010-04-20),

Title: The Innovative Contributions of Brian Herbert in Nicotinic Acetylcholine Receptor Research

Introduction

Brian Herbert is an accomplished inventor based in Stockholm, New Jersey, and he holds an impressive portfolio of 21 patents. His work primarily revolves around the field of pharmacology, focusing on the development of ligands for nicotinic acetylcholine receptors, which play a crucial role in neurotransmission in the brain. Herbert’s contributions are significant in advancing treatments for disorders related to dysfunctional nicotinic receptors.

Latest Patents

Herbert's latest patents include innovations related to indazoles, benzothiazoles, benzoisothiazoles, and benzisoxazoles. These compounds are recognized for their potential as ligands for the α7 nicotinic acetylcholine receptor subtype. His patented inventions address the activation of nACh receptors and aim to provide therapeutic solutions for various diseases caused by defective or malfunctioning nicotinic acetylcholine receptors. Furthermore, Herbert's patents describe methods for preparing these novel compounds and their application in medicinal formulations.

Career Highlights

Throughout his career, Brian Herbert has worked with notable entities such as Memory Pharmaceuticals Corporation, contributing to cutting-edge research and development in the pharmaceutical industry. His extensive knowledge and expertise in the design and functionalization of pharmacological agents have positioned him as a respected figure in the field.

Collaborations

Herbert has collaborated with leading professionals, such as Wenge Xie and Ashok Tehim, enhancing the breadth and impact of his research. These collaborations have facilitated innovative advancements in therapeutic strategies targeting nicotinic acetylcholine receptors.

Conclusion

In summary, Brian Herbert has made noteworthy strides in the domain of receptor research, with a focus on creating effective therapeutic agents through his innovative patents. His continued work holds promise for improving treatments for conditions related to nicotinic acetylcholine receptor malfunctions, signifying the importance of his contributions to pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…